Market Highlights
Respiratory care devices are used for treating, controlling, evaluating, managing, and diagnosing patients with an anomaly in the cardiopulmonary system. The respiratory disease is any of the diseases and disorders of the airways and the lungs that affect human breathing. Diseases of the respiratory system may disturb any of the structures and organs that have to do with breathing, which includes nasal cavities, the throat, the larynx, the trachea, the tissues of the lungs, and the respiratory muscles of the chest cage.
The growing respiratory diseases are largely due to increasing patient population suffering from chronic diseases, which include chronic obstructive pulmonary disease (COPD), cystic fibrosis, pneumonia, and asthma. The initial detection of these diseases aids in providing better treatments. Thus, the demand for respiratory care devices market share is increasing greatly in the global market. Additionally, the growing elderly population vulnerable to respiratory problems would boost the demand for the respiratory care devices market.
The lack of awareness about respiratory problems, intense competition, and the cost associated with the device and the respiratory surgery hamper the growth of the market.
Regional Analysis
The Americas is projected to lead the respiratory devices market during the forecast period. Increasing healthcare awareness, advancement in technology, and medical tourism are some other factors that boost the growth of the market. According to the statistics of Life and Breath, on an average 72 Canadians were diagnosed with lung cancer daily and 56 Canadians died from lung cancer on a daily basis in 2014.
The European market is expected to hold the second largest market share. According to the statistics of the British Lung Foundation in the year 2014, around 10,000 people in the UK are newly diagnosed with a respiratory disease every week. According to the statistics of the British Lung Foundation, lung diseases are accountable for more than 7,00,000 hospital admissions and over 6 million inpatient bed-days in the UK each year.
Asia-Pacific is projected to be the fastest growing region for the global respiratory care devices market in 2018. The market is expected to witness growth owing to the rising patient population, changing lifestyle, and growing elderly population. This is expected to provide favorable backgrounds for the market to grow. According to the Asia-Pacific Lung Cancer Conference (APLCC), 90% of the lung cancer cases are due to the rise in the consumption of tobacco.
The Middle East and Africa accounts for the least share due to stringent government policies and low per capita income.
Segmentation
The global respiratory care devices market has been segmented on the basis of therapeutic devices, monitoring devices, diagnostic devices, accessories and consumables, application, and end-users. On the basis of therapeutic devices, the market has been classified as pap devices, masks, ventilators, nebulizers, humidifiers, oxygen concentrators, inhalers, reusable resuscitators, nitric oxide delivery units, and oxygen hoods. On the basis of monitoring devices, the market has been classified as pulse oximeters, pulse oximeter sensors, pulse oximeter equipment, capnographs, and gas analyzers. On the basis of diagnostic devices, the market has been classified as spirometers, polysomnography (PSG) devices, peak flow meters, and other diagnostic devices. On the basis of accessories and consumables, the market has been classified as disposable masks, disposable resuscitators, tracheostomy tubes, nasal cannulas, and other consumables and accessories. On the basis of application, the market has been classified as chronic obstructive pulmonary disease (COPD), sleep apnea, asthma, infectious diseases, and other diseases. On the basis of end-users, the market has been classified as hospitals, clinics, ambulatory care, home care, and others.
Respiratory Care Devices Market Players
· Philips Healthcare (The Netherlands)
· ResMed
· Inc. (US)
· Medtronic plc (Ireland)
· Masimo Corporation (US)
· Fisher & Paykel Healthcare Corporation Limited (New Zealand)
· Becton
among others are some key companies in the global Respiratory Care Devices that are listed by MRFR for market research.
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
